Lisa Kao Email

Rebates Associate . Actelion

South San Francisco, CA

Location

Current Roles

Employees:
4008
Revenue:
$0
About
Actelion Ltd is a Swiss biopharmaceutical company that focuses on the discovery and development of treatments to serve unmet medical needs. Its products specialize in conditions related to the endothelium. The Company has three approved drugs on the market. Tracleer, an orally available dual endothelin receptor antagonist, has been approved as a therapy for pulmonary arterial hypertension, a chronic, life-threatening disorder that severely compromises the functions of the lungs and heart. Ventavis is an inhaled formulation of iloprost, a synthetic analogue of prostacyclin PGI2 that dilates systemic and pulmonary arterial vascular beds. It also affects platelet aggregation. The third drug, Zavesca, was in-licensed from Oxford GlycoSciences. Zavesca is an approved oral treatment for type 1 Gaucher disease, a rare debilitating metabolic disorder. In addition, the Company was evaluating nine compounds in various phases of clinical development in 2007.
Actelion Address
5000 Shoreline Ct
South San Francisco, CA
United States
Actelion Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.